Healthtech Series C Investors & VC Firms
771 firms in this list, with a median first check of $1M. 164 of them lead rounds. Generated from verified public data and updated continuously.
Goodwater Capital
BurlingamePre-Seed–Late Stage$5M – $50M
10 people
Korelya Capital
ParisSeed–Series C
21 people
Better Ventures Central Llc
OaklandPre-Seed–Growth$500K – $1.5M
4 people
Tenmile
Seed–Growth
11 people
MaRS
TorontoPre-Seed–Late Stage
19 people
Informed Ventures Advisors, Llc
Menlo ParkPre-Seed–Late Stage
8 people
Allumia Ventures
SeattleSeries A–Late Stage$5M – $15M
11 people
IW Capital
LondonSeed–Growth
16 people
Ascendo Ventures
SeoulPre-Seed–Late Stage
9 people
Delos Capital
CambridgeSeed–Late Stage
12 people
Prime Partners
TokyoPre-Seed–Growth
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
19 people
Vensana Capital
MinneapolisSeries A–Late Stage
13 people
SQN Venture Partners, LLC
CharlestonSeed–Late Stage
7 people
NovaCapital
Seed–Late Stage
9 people
Bamboo Capital Partners
LuxembourgSeed–Growth
22 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
DeepTechXL
EindhovenPre-Seed–Series C$108K – $2.2M
16 people
Lifeforce Capital
Chevy ChaseSeed–Series C$500K – $5M
4 people
WELL Ventures
VancouverSeed–Growth
16 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Related lists
Healthtech Investors & VC Firms (3208)Series C Investors & VC Firms (2751)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Series C Investors & VC Firms in United States (946)Series C Investors & VC Firms in Global (896)
Data sourced from public filings and firms' own websites — see our methodology.









































































